TARSUS PHARMACEUTICALS INC's ticker is TARS and the CUSIP is 87650L103. A total of 107 filers reported holding TARSUS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.53 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,352,843 | +16.3% | 526,260 | +18.3% | 0.00% | 0.0% |
| Q2 2023 | $8,038,638 | +83.2% | 444,861 | +27.4% | 0.00% | 0.0% |
| Q1 2023 | $4,388,802 | +87658.5% | 349,149 | +2.3% | 0.00% | 0.0% |
| Q4 2022 | $5,001 | -99.9% | 341,191 | +3.6% | 0.00% | 0.0% |
| Q3 2022 | $5,640,000 | +45.2% | 329,481 | +23.8% | 0.00% | 0.0% |
| Q2 2022 | $3,884,000 | +76.6% | 266,084 | +103.5% | 0.00% | – |
| Q1 2022 | $2,199,000 | -22.3% | 130,758 | +3.9% | 0.00% | – |
| Q4 2021 | $2,830,000 | +6.2% | 125,815 | +1.7% | 0.00% | – |
| Q3 2021 | $2,665,000 | -26.7% | 123,698 | -1.5% | 0.00% | -100.0% |
| Q2 2021 | $3,637,000 | +10.9% | 125,521 | +23.3% | 0.00% | 0.0% |
| Q1 2021 | $3,281,000 | -28.1% | 101,809 | -7.8% | 0.00% | 0.0% |
| Q4 2020 | $4,561,000 | – | 110,375 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 2,084,370 | $30,432,000 | 4.62% |
| Vivo Capital, LLC | 2,312,368 | $33,761,000 | 3.39% |
| Frazier Life Sciences Management, L.P. | 1,787,527 | $26,098,000 | 2.46% |
| Cormorant Asset Management, LP | 1,875,000 | $27,375,000 | 2.07% |
| Sands Capital Ventures, LLC | 260,000 | $3,796,000 | 1.04% |
| Ghost Tree Capital, LLC | 120,000 | $1,752,000 | 0.91% |
| RTW INVESTMENTS, LP | 2,013,601 | $29,399,000 | 0.76% |
| COWEN AND COMPANY, LLC | 534,524 | $7,804,000 | 0.75% |
| Perceptive Advisors | 1,296,416 | $18,927,000 | 0.59% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,324,214 | $19,334,000 | 0.40% |